← Eichor
Condition: Thrombocytopenia Alloimmune Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Thrombocytopenia Alloimmune

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Impact of Thrombocytopenia and Platelet Transfusions on Neonatal Bleeding and Inflammation
Phase N/A · 2 location(s) · Boston Children's Hospital · NCT03848923An Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Primary Immune Thrombocytopenia
EARLY_Phase 1 · 1 location(s) · Changzhou No.2 People's Hospital · NCT06337474The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia
Phase N/A · 8 location(s) · Karolinska Institutet · NCT04598750A Study of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
Phase 3 · 21 location(s) · Janssen Research & Development, LLC · NCT06449651A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thro
Phase 3 · 26 location(s) · Janssen Research & Development, LLC · NCT06533098
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.